RadNet price target raised to $81 from $74 at Truist

Truist raised the firm’s price target on RadNet (RDNT) to $81 from $74 and keeps a Buy rating on the shares. The firm is bullish on the stock following its upbeat management meetings that highlighted robust core imaging center demand trends alongside a wide range of areas of opportunity for the company, supported by ongoing brisk investment in Digital Health, the analyst tells investors in a research note. RadNet is also well positioned to augment core trends via opportunistic M&A, Truist added.